Galapagos NV Catalyst Calendar

Proactively evaluate Galapagos NV’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

A sample of Galapagos NV Catalyst Calendar data

Event Date Event Type Company Name Ticker Symbol Drug Name Therapy Area Indication Source Type
Showing 3 of 110+ results. Subscribe to unlock more.
01 Nov 2019 GDCTXXXX Lorem Lorem Lorem XXXX Planned Lorem
01 Nov 2019 Phase III Trial Initiation Galapagos NV; Gilead Sciences Inc GILD; GLPG filgotinib maleate Immunology; Musculoskeletal Disorders Plaque Psoriasis (Psoriasis Vulgaris); Psoriasis; Psoriatic Arthritis Clinical Trial Registry
01 Nov 2019 Phase I Trial Completion Galapagos NV GLPG aldumastat Musculoskeletal Disorders Osteoarthritis Clinical Trial Registry
30 Sep 2019 Phase II Trial Results Galapagos NV; Gilead Sciences Inc; ICON Plc GILD; GLPG; ICLR filgotinib maleate; lanraplenib succinate Immunology Cutaneous Lupus Erythematosus Company Presentation
Catalyst Calendar


Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.



  • Trial Events for trials conducted globally by a company, university, institute or CRO:  Trial Initiation, Trial Completion, Trial Results
  • Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
  • Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)


Proactively evaluate companies and catalyst impacts

Stay ahead of the competition & improve corporate planning

Bolster business development with timely opportunities

Premium databases is part of our industry range of products

Subscribe to Company Analytics & gain 12-month access to premium industry data & analytics
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.


Access more premium companies when you subscribe to Explorer